Concepedia

Publication | Closed Access

Fixed Duration Therapy with Daratumumab, Carfilzomib, Lenalidomide and Dexamethasone for High Risk Smoldering Multiple Myeloma-Results of the Ascent Trial

37

Citations

0

References

2022

Year

No additional data available for this publication yet. Check back later!